Home > Insider Trading > Filing (0001140361-14-004509)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1559053	Prothena Corp Plc	PRTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
737572	Elan Corp Plc	Treasury Building Lower Grand Canal Street Dublin 2 L2 00000	No	No	Yes	No
1565579	Ltd One Science Elan	Treasury Building Lower Grand Canal Street Dublin L2 DUBLIN 2	No	No	Yes	No
1585364	Perrigo Co Plc	Treasury Building Lower Grand Canal Street Dublin 2 L2	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2014-02-03	3,182,253	$24.96	0	No	4	S	Indirect	Indirect

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Indirect

Footnotes

The shares were sold by Elan Science One Limited ("ES1") in connection with a marketed underwritten registered offering pursuant to a shelf registration statement on Form S-3 filed by Prothena Corporation plc with the Securities and Exchange Commission (the "SEC") on January 17, 2014, which the SEC declared effective on January 24, 2014 (File No. 333-193416).
Represents a price to the public of $26.00 per ordinary share less the underwriting discount.
Shares directly owned by ES1. ES1 is an indirect, wholly-owned subsidiary of Perrigo Company plc and Elan Corporation Limited (formerly Elan Corporation, plc).